Next Pick
Earnings DeskOpen the stock page →

Royalty Pharma plc · Biotechnology

RPRXRoyalty Pharma plc

Reports 2026-11-04 Pre-market · WedReaction day 11-04upcoming

Before the print · expectationsReports today

The record · last 8 prints

8/8
beat the EPS consensus
±2.0%
average first-day moveclosed higher 6 of 8 times
1/8
moved more than options impliedusually stays inside the implied move

Move ruler · first session

−5%+5%

The options-implied move posts once the event straddle is read, by the night before the print.

Pricing going in · as of the 11-03 close

+17.6%Move over the last 20 sessionsLast 5 sessions +1.7%
+7.5 ptsvs sector (XLV)XLV over the same window +10.1%
—Forward P/EConsensus: not available

What the record doesn't tell you

Beat estimates 8 of 8 times. So which way does RPRX go on 11‑04?

  • Model lean for 11-04, and the evidence behind it
  • Move band, P10 – P90
  • Last 8 prints, quarter by quarter
  • Peers that already reported, and how they traded
Start 30-day free trialFull access · no card requiredHave an account? Sign inThe lean freezes the night before the print.

The print · 8-K and callupcoming · 2026-11-04 · Pre-market

Revenue$890M
est. —
EPS—
est. —
Guidance · FY revenue$3.50B–$3.55B
vs consensus +0.6% · Consensus $3.51B

Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →

Royalty Pharma earnings preview: what the record says

Royalty Pharma (RPRX) is scheduled to report earnings on Nov 4, 2026, before the open.

Across its last 8 reports, RPRX beat the EPS consensus 8 times out of 8 with a figure on file, and the stock moved an average of 2.0% on the first trading day, closing higher 6 of 8 times. That first-day move was larger than the options-implied move in 1 of 8 reports. Measured over five sessions, the average move was 3.0%.

Historically, RPRX has usually stayed inside its implied move. Beats have mostly been rewarded: RPRX closed higher after 6 of its 8 EPS beats.

Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.

RPRX earnings: key questions

When is RPRX's next earnings date?

Royalty Pharma is scheduled to report on Nov 4, 2026, before the open.

How much does RPRX stock move after earnings?

Over its last 8 reports, RPRX moved an average of 2.0% on the first trading day after earnings. The move was larger than the options-implied move in 1 of 8 reports.

Does RPRX usually beat earnings estimates?

RPRX beat the EPS consensus in 8 of its last 8 reports with a surprise on file and missed in 0.